Moderate Drug Interaction

Can You Take Paracetamol with Amitriptyline?

A plain-English look at the moderate interaction between Paracetamol (PHARMACY CARE PARACETAMOL) and Amitriptyline (ENTRIP) — what it means, why it happens, and what to talk to your doctor or pharmacist about.

Reviewed by , Registered Pharmacist
Last reviewed: How we research and review
Moderate severity AllMeds interaction database

Combining Paracetamol (PHARMACY CARE PARACETAMOL) with Amitriptyline (ENTRIP) is a moderate interaction requiring caution and monitoring. Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.

Not sure about your specific combination? Check it in the Drug Interaction Checker →

Key Takeaways

  • Interaction severity: Moderate
  • Risk: Serotonin syndrome (agitation, hyperthermia, rigidity), excessive sedation.
  • Mechanism: Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
  • Paracetamol: S2 in Australia, low risk
  • Amitriptyline: S4 in Australia, moderate risk
  • Claims action: Monitor and document. Request clinical justification if combination is ongoing.

Paracetamol vs Amitriptyline at a Glance

Property Paracetamol Amitriptyline
Brand names PHARMACY CARE PARACETAMOL, Wagner Health Paracetamol, Paracetamol Sandoz Pharma ENTRIP, Amitriptyline Lupin, APX-Amitriptyline
Drug class opioid antidepressant
Risk level low moderate
TGA Schedule (AU) S2 S4

Why Is This Combination Dangerous?

Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.

Clinical risk: Serotonin syndrome (agitation, hyperthermia, rigidity), excessive sedation.

Regulatory Guidance by Jurisdiction

Australia TGA / SIRA / WorkSafe

The TGA and Australian Medicines Handbook classify this as a moderate drug interaction requiring monitoring and clinical review.

United Kingdom NICE / MHRA / FPM

NICE guidelines advise against combining multiple serotonergic medications due to the risk of serotonin syndrome. For personal injury claims, antidepressant prescribing should be reviewed for injury relatedness and appropriateness.

United States FDA / CDC / State WC

The FDA has issued Drug Safety Communications about the risk of serotonin syndrome with concurrent use of serotonergic medications. Workers compensation nurse case managers should flag this combination for prescriber review.

What Claims Professionals Should Do

  1. Document the combination in the claim file with a note on interaction risk
  2. Request clinical justification from the prescriber at the next review
  3. Monitor for adverse effects including excessive sedation, falls, and cognitive impairment
  4. Assess injury relatedness of both medications to the compensable condition
  5. Review at next claim assessment and consider whether the combination is still clinically appropriate

Clinical reference

Informational Theoretical

A clinical summary of Paracetamol and Amitriptyline drawn from regulator advisories, national guidelines, and authoritative drug references. Read this if you want the deeper clinical picture before talking to your prescriber or pharmacist.

Severity assessment

Informational. There are no known significant adverse drug interactions between amitriptyline and paracetamol that would typically warrant a higher severity classification. Some studies suggest a synergistic effect for pain relief, which is not an adverse interaction.

Mechanism (plain English)

Amitriptyline is a tricyclic antidepressant that works by increasing the levels of certain chemical messengers in the brain, such as serotonin and norepinephrine, which helps improve mood and can also have pain-relieving effects. Paracetamol (acetaminophen) is a common pain reliever and fever reducer, thought to work primarily in the central nervous system by inhibiting prostaglandin synthesis. While some preclinical studies suggest that combining amitriptyline and paracetamol may lead to an enhanced pain-relieving effect (synergistic antinociception), there is no clear evidence of pharmacokinetic or pharmacodynamic interactions that would cause increased toxicity or adverse effects when used together at therapeutic doses. Both drugs are metabolized in the liver, but they generally use different pathways, minimizing competitive inhibition.

Evidence level

Theoretical. The absence of significant adverse interactions is supported by multiple drug interaction databases and clinical information resources. Preclinical studies suggest a synergistic antinociceptive effect, but this is not an adverse interaction and requires further clinical validation.

Top regulator advisories (cite verbatim or close paraphrase)

  • TGA (Australia): No specific public advisory for the amitriptyline + paracetamol pair was found. General product information for amitriptyline (e.g., AMITRIPTYLINE-WGR, ARTG 333522) and paracetamol (e.g., PANADOL TABLETS, ARTG 13591) does not highlight this specific interaction as a concern.
  • MHRA / NICE (UK): The NICE British National Formulary (BNF) interactions checker for amitriptyline does not list paracetamol as an interacting drug, indicating no significant interaction is recognized [1].
  • FDA / CDC (US): No specific FDA label warning or safety communication regarding an interaction between amitriptyline and paracetamol (acetaminophen) was found. The FDA label for Amitriptyline Hydrochloride Tablets, USP, focuses on interactions with MAOIs and cisapride, and general warnings about suicidality and serotonin syndrome, without mentioning paracetamol [2].
  • EMA (Europe): No specific EMA guidance or advisory for this drug pair was identified.

Clinical risk factors that elevate the danger

Given the lack of significant interaction, there are no specific clinical risk factors that are uniquely elevated by the combination of amitriptyline and paracetamol. However, patients should be aware of the general risks associated with each medication:

  • Amitriptyline: Drowsiness, dizziness, dry mouth, constipation, blurred vision, urinary retention, and potential for cardiac effects (especially in overdose). It can also increase the risk of falls, particularly in older adults. Serotonin syndrome is a risk when combined with other serotonergic drugs, but paracetamol is not typically considered serotonergic.
  • Paracetamol: Liver damage (hepatotoxicity) with overdose, especially in individuals with pre-existing liver conditions or those who consume alcohol regularly. Allergic reactions are rare but possible.

What a patient should be told

  • You can generally take paracetamol with amitriptyline for pain relief. However, both medicines can cause drowsiness, so be cautious when driving or operating machinery until you know how they affect you.
  • Always stick to the recommended doses for both medications. Taking too much paracetamol can cause serious liver damage, even if you feel fine initially.
  • If you experience any unusual symptoms like severe drowsiness, confusion, yellowing of the skin or eyes, or unusual bleeding/bruising, stop taking the medicines and seek urgent medical attention.
  • Do not stop taking amitriptyline suddenly without talking to your doctor, as this can lead to withdrawal symptoms.
  • If you have any concerns about combining these medications or if your pain is not well-controlled, discuss safer alternatives or dose adjustments with your doctor or pharmacist.

Top 3 sources (with full citation)

  1. NICE. Amitriptyline | Interactions | BNF. National Institute for Health and Care Excellence. Available at: https://bnf.nice.org.uk/interactions/amitriptyline/ (Accessed: June 1, 2026).
  2. U.S. Food and Drug Administration. Amitriptyline Hydrochloride Tablets, USP. Label. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/085968s112lbl.pdf (Accessed: June 1, 2026).
  3. Garrido-Suárez BB, et al. Synergistic interaction between amitriptyline and paracetamol in persistent and neuropathic pain models: An isobolografic analysis. Pharmacology Biochemistry and Behavior. 2021;206:173206. Available at: https://pubmed.ncbi.nlm.nih.gov/34411687/ (Accessed: June 1, 2026).

Notes for the reviewing pharmacist

While several online drug interaction checkers classify this interaction as minor or informational, the primary literature and regulatory advisories do not indicate a significant adverse interaction. The synergistic antinociceptive effect observed in preclinical studies (Garrido-Suárez et al., 2021) is an interesting finding that could potentially lead to future clinical applications, but it does not represent an adverse drug interaction in the traditional sense. Pharmacists should reassure patients that this combination is generally safe when used at recommended doses, while still emphasizing general medication safety principles, particularly regarding paracetamol overdose and amitriptyline's anticholinergic and sedative side effects. There are no common misconceptions about this specific pair, but general patient education on polypharmacy and potential side effects of each drug is always warranted.

Source metadata JSON

{
  "pair": "amitriptyline + paracetamol",
  "severity": "Informational",
  "evidence_level": "Theoretical",
  "source_urls": "https://bnf.nice.org.uk/interactions/amitriptyline/;https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/085968s112lbl.pdf;https://pubmed.ncbi.nlm.nih.gov/34411687/"
}
Sources used in this brief (3)

Check this medication against your full medication list

Check all interactions for Paracetamol and Amitriptyline across your claimant's full medication list.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Related Resources

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.